当前位置:首页 - 行情中心 - 康辰药业(603590) - 财务分析

康辰药业

(603590)

  

流通市值:84.73亿  总市值:85.77亿
流通股本:1.57亿   总股本:1.59亿

康辰药业(603590)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润0.96亿元,每股收益0.58元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益340581.22万元,未分配利润196029.20万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产387181.57万元,负债46600.35万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入460,869,253.77212,002,399.05825,397,797.2646,310,729.73
营业总成本340,875,691.38152,416,687.23696,236,061.61518,431,065.74
其他经营收益
营业利润121,192,249.9356,852,397.8139,087,805.17144,401,420.69
利润总额109,767,887.2655,550,359.9138,863,747.55144,212,254.67
净利润96,334,639.1948,137,550.3721,530,544.55123,523,551.66
每股收益
其他综合收益-44,025,848.89-38,283,346.8658,297,183.2751,595,510.65
综合收益总额52,308,790.39,854,203.5179,827,727.82175,119,062.31
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计1,377,549,887.351,192,375,175.061,086,540,037.051,134,614,428.36
非流动资产:
非流动资产合计2,494,265,812.382,692,793,179.962,833,148,853.42,861,441,889.75
资产总计3,871,815,699.733,885,168,355.023,919,688,890.453,996,056,318.11
流动负债:
流动负债合计333,523,462.39312,765,161.81352,683,215.26319,470,870.04
非流动负债:
非流动负债合计132,480,066.11132,739,009.6140,841,678.43159,171,916.1
负债合计466,003,528.5445,504,171.41493,524,893.69478,642,786.14
所有者权益(或股东权益):
归属于母公司股东权益合计3,118,771,943.973,154,272,355.953,144,412,325.673,204,427,809.26
股东权益合计3,405,812,171.233,439,664,183.613,426,163,996.763,517,413,531.97
负债和股东权益合计3,871,815,699.733,885,168,355.023,919,688,890.453,996,056,318.11
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计407,103,252.66175,703,267.06915,836,361.4674,682,303.42
经营活动现金流出小计418,780,386.38207,215,474.39743,591,182.91562,965,201.21
经营活动产生的现金流量净额-11,677,133.72-31,512,207.33172,245,178.49111,717,102.21
投资活动产生的现金流量:
投资活动现金流入小计831,574,895.41171,164,986.291,300,620,310.47964,139,668.82
投资活动现金流出小计587,583,874.14132,522,406.221,499,020,597.18996,664,252.99
投资活动产生的现金流量净额243,991,021.2738,642,580.07-198,400,286.71-32,524,584.17
筹资活动产生的现金流量:
筹资活动现金流入小计84,705,761.6239,659,140227,232,614.94170,397,915.69
筹资活动现金流出小计140,690,367.3724,636,813.3235,503,922.34166,522,349.1
筹资活动产生的现金流量净额-55,984,605.7515,022,326.7-8,271,307.43,875,566.59
汇率变动对现金及现金等价物的影响7,729.741,218.83-2,816,383.01-2,528,969.64
现金及现金等价物净增加额176,337,011.5422,153,918.27-37,242,798.6380,539,114.99
期末现金及现金等价物余额366,314,713.38212,131,620.11189,977,701.84307,759,615.46
补充资料:
现金及现金等价物的净增加额176,337,011.54--37,242,798.63-
最新报告期:2025-09-08
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
太平洋谭紫媚0.941.161.352025-09-08
国盛证券张玉,张金洋,胡偌碧0.951.151.382025-09-05
首创证券王斌1.061.271.522025-09-02
平安证券叶寅,韩盟盟0.831.111.342025-08-29
中航证券李蔚0.871.111.322025-08-29
TOP↑